François P. Duhoux - Concepedia

Author

François P. Duhoux

Cliniques Universitaires Saint-Luc ORCID

Also Known As

Duhoux, François, Duhoux, François P., F Duhoux, F P Duhoux, F. Duhoux, F. P. Duhoux, F.P. Duhoux, Francois Duhoux, Francois P Duhoux, Francois P. Duhoux

268

Publications

Citations

H-Index

Concepts

All Affiliations

Cliniques Universitaires Saint-Luc UCLouvain KU Leuven Institut Jules Bordet Université Libre de Bruxelles

About

François P. Duhoux is an author at Cliniques Universitaires Saint-Luc specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.2K
2	Health Sciences	5	5	715
3	Cell Biology	3	3	73
4	Nursing	1	1	231
5	Anatomy	1	1	118

François P. Duhoux

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Rashmi K. Murthy, Sherene Loi, Alicia Okines, New England Journal of Medicine	2019	1.3K
Phase I Study of <sup>68</sup>Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Journal of Nuclear Medicine	2015	419
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial Fabrice André, Yeon Hee Park, Sung‐Bae Kim, The Lancet Breast OncologyMedicineClinical TrialsBreast CancerPharmacotherapy	2023	313
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer Wee Loon Ong, Maartje G. Schouwenburg, A.C.M. van Bommel, JAMA Oncology Surgical OncologyCancer ManagementPrognosisValue TheoryCancer Registration	2016	231
Somatic Uniparental Isodisomy Explains Multifocality of Glomuvenous Malformations Mustapha Amyere, Virginie Aerts, Pascal Brouillard, The American Journal of Human Genetics UrologyOculoplasticsHistopathologyVascular MalformationGlomuvenous Malformations	2013	118
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Journal of Nuclear Medicine Breast OncologyHealthy SubjectsTumor BiologyRadiation MedicineBreast Cancer Patients	2020	116
<i>PRDM16</i> (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies François P. Duhoux, Geneviève Ameye, Carmen P. Montano‐Almendras, British Journal of Haematology	2011	57
The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy Martine Berlière, Fabienne Roelants, Christine Watremez, The Breast Breast Cancer SurgeryBreast OncologyHypnosis InterventionBreast CancerSurgery	2017	54
Letrozole and palbociclib versus 3rd generation chemotherapy as neoadjuvant treatment of minal breast cancer. Results of the UNICANCER-eoPAL study P. Cottu, Véronique D’Hondt, Sylvain Dureau, Annals of Oncology Minal Breast CancerBreast OncologyUnicancer-eopal StudyGeneration ChemotherapyMedicine	2017	52
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants Matteo Lambertini, Marcello Ceppi, Anne‐Sophie Hamy, npj Breast Cancer	2021	36

Page 1